Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.8K Buy
245
+78
+47% +$26.7K 0.02% 195
2026
Q1
$58.8K Buy
+167
New +$59.5K 0.02% 233
2025
Q4
Sell
-167
Closed -$47.2K 111
2025
Q3
$47.2K Buy
167
+1
+0.6% +$290 0.01% 255
2025
Q2
$46.3K Buy
166
+1
+0.6% +$283 0.02% 250
2025
Q1
$51.3K Sell
165
-99
-38% -$29.2K 0.02% 237
2024
Q4
$68.6K Buy
264
+2
+0.8% +$593 0.03% 191
2024
Q3
$84.4K Buy
262
+1
+0.4% +$327 0.03% 177
2024
Q2
$81.2K Sell
261
-10
-4% -$2.94K 0.03% 198
2024
Q1
$76.7K Buy
271
+10
+4% +$2.93K 0.03% 227
2023
Q4
$75.2K Buy
+261
New +$71.1K 0.03% 309

Other funds holding AMGN

Main Street Group's AMGN Position: Q2 2026 in Review

Main Street Group increased its Amgen (AMGN) stake by 47% in Q2 2026, buying an estimated $26.7K and bringing the position to 245 shares worth $88.8K. The position accounts for 0.02% of the portfolio, ranked #195.

Main Street Group first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Main Street Group held 245 shares of Amgen worth $88.8K as of Q2 2026.
  • Main Street Group bought 78 Amgen shares in Q2 2026, an estimated $26.7K.
  • Amgen made up 0.02% of Main Street Group's portfolio in Q2 2026, its #195 holding.
  • Main Street Group first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.